Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q8WW38: Variant p.Met544Ile

Zinc finger protein ZFPM2
Gene: ZFPM2
Feedback?
Variant information Variant position: help 544 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Methionine (M) to Isoleucine (I) at position 544 (M544I, p.Met544Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In SRXY9 and TOF; reduced its ability to interact with GATA4. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 544 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1151 The length of the canonical sequence.
Location on the sequence: help VHRRLRHGSSSYPPVIYSPL M PKGATCFECNITFNNLDNYL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         VHRRLRHGSSSYPPVIYSPLMPKGATCFECNITFNNLDNYL

Mouse                         VHRRLRHGSSSYPPVIYSPLMPKGATCFECNITFNNLDNYL
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1151 Zinc finger protein ZFPM2
Zinc finger 542 – 575 CCHC FOG-type 2
Binding site 550 – 550
Binding site 553 – 553
Modified residue 532 – 532 Phosphoserine



Literature citations
Mutations in the FOG2/ZFPM2 gene are associated with anomalies of human testis determination.
Bashamboo A.; Brauner R.; Bignon-Topalovic J.; Lortat-Jacob S.; Karageorgou V.; Lourenco D.; Guffanti A.; McElreavey K.;
Hum. Mol. Genet. 23:3657-3665(2014)
Cited for: INTERACTION WITH GATA4; INVOLVEMENT IN SRXY9; VARIANTS SRXY9 GLN-260; ARG-402 AND ILE-544; VARIANTS GLY-403 AND ASP-782; CHARACTERIZATION OF VARIANTS GLN-260 AND ARG-402; New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle.
De Luca A.; Sarkozy A.; Ferese R.; Consoli F.; Lepri F.; Dentici M.L.; Vergara P.; De Zorzi A.; Versacci P.; Digilio M.C.; Marino B.; Dallapiccola B.;
Clin. Genet. 80:184-190(2011)
Cited for: VARIANT TOF ILE-544; VARIANTS CTHM GLY-30 AND VAL-227;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.